Carbopol 934-P loaded with vildagliptin for diabetic delivery: In vitro and in vivo evaluation of nanoparticles

Current Nanoscience

Volumn 9, Issue 5, 2013, Pages 642-647

  Sree Harsha, N ^a   Aldhubiab, Bander E ^a   Alhaider, Ibrahim Abdulrahman ^a   Attimarad, Mahesh ^a   Nair, Anroop ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Carbopol; Diabetic; Nanoparticles; Shriveled; Spraydrying; Vildagliptin

Indexed keywords

CONTROLLED DRUG DELIVERY; NANOPARTICLES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING;

BIMODAL PARTICLE SIZE DISTRIBUTION; CARBOPOL; DIABETIC; GASTROINTESTINAL TRACT; MORPHOLOGICAL PROPERTIES; MUCOADHESIVE POLYMERS; SHRIVELED; VILDAGLIPTIN;

TARGETED DRUG DELIVERY;

CARBOMER; NANOPARTICLE; VILDAGLIPTIN;

ANGLE OF REPOSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS MEMBRANE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; ELECTRON MICROSCOPY; GASTROINTESTINAL TRACT; IN VITRO STUDY; IN VIVO STUDY; INFRARED RADIATION; INFRARED SPECTROSCOPY; INTESTINE TRANSIT TIME; NONHUMAN; PARTICLE SIZE; POWDER FLOW; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING;

RATTUS;

EID: 84884238912     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/15734137113099990086     Document Type: Article

References (49)

1. Kikuchi, M.; Haneda, M.; Koya, D.; Tobe, K.; Onishi, Y.; Couturier, A.; Mimori, N.; Inaba, Y.; Goodman, M. Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract., 2010, 89, 216-223.
2. Dong, H-Q; Li, M.; Zhu, F.; Liu, F-L; Huang, J-B. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. Food Chem., 2011, 130, 261-266.
3. Farag, Y.M.K.; Gaballa, M. R. Diabesity: an overview of a rising epidemic. Nephrol. Dial. Transplant., 2011, 26, 28-35.
4. Kheir, N.; Zaidan, M.; Younes, H.; Hajj, M.E.; Wilbur, K.; Jewesson, P.J. Pharmacy Education and Practice in 13 Middle Eastern Countries. Am. J. Pharm. Educ., 2009, 72 133.
5. Elhadd Tarik, A.; Al-Amoudi Abdallah, A.; Alzahrani Ali S. Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: A review. Am. J. Pharm. Educ. 2007, 27, 241-250.
6. Datamonitor. Summary of the "Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets" report. 2008, 12, 241-250.
7. Kikuchi, M.; Abe, N.; Kato, M.; Terao, S.; Mimori, N.; Tachibana, H. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract., 2009, 83, 233-240.
8. Ahrén, B.; Schweizer, A.; Dejager, S.; Villhauer, E. B.; Dunning, B. E.; Foley, J. E. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes. Metab., 2011, 13, 775-783.
9. He, H.; Tran, P.; Yin, H.; Smith, H.; Batard, Y.; Wang, L.; Einolf, H.; Gu, H.; Mangold, J. B.; Fischer, V.; Howard, D. Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans. Drug Metab. Dispos., 2009, 37, 536-544.
10. Vincent, S.H.; Reed, J.R.; Bergman, A.J.; Elmore, C.S.; Zhu, B.; Xu, S.; Ebel, D.; Larson, P.; Zeng, W.; Chen, L.; Dilzer, S.; Lasseter, K.; Gottesdiener, K.; Wagner, J.A.; Herman, G.A. Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans. Drug Metab. Dispos., 2007, 35, 533-538.
11. Doherty, R. Vildagliptin successful in treating type 2 diabetes. Nat. Clin. Pract. End. Met., 2006, 2, 6-6.
12. Sunkara, G.; Sabo, R.; Wang, Y.; He, Y-L.; Campestrini, J.; Rosenberg, M.; Howard, D.; Dole, W. P. Dose Proportionality and the Effect of Food on Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, in Healthy Volunteers. J. Clin. Pharmacol., 2007, 47, 1152-1158.
13. Singh, B.; Chakkal, S.K.; Ahuja, N. Formulation and Optimization of Controlled Release Mucoadhesive Tablets of Atenolol Using Response Surface Methodology. AAPS Pharm. Sci. Tech., 2006, 7, E-1-10.
14. Ponchel, G.; Irache, J-M. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev., 1998, 34, 191-219.
15. Moulari, B.; Beduneau, A.; Pellequer, Y.; Lamprecht, A. Nanoparticle Targeting to Inflamed Tissues of the Gastrointestinal Tract. Curr. Drug Deliv. 2013, 10, 9-17.
16. Harsha, S.; Attimarad, M.; Khan, T.; Anroop, N.; Aldhubiab, B.; Sangi, S.; Shariff, A. Design and formulation of mucoadhesive microspheres of sitagliptin. J. Microencapsul., 2012, IN PRESS.
17. Su, X.; Zhan, X.; Tang, F.; Yao, J.; Wu, J. Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery. Curr. Nanosci. 2011, 7, 37-46.
18. Harsha, S. Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres. Int. J. Nanomed., 2012, 7, 4787-4796.
19. Li, X.; Anton, N.; Arpagaus, C.; Belleteix, F.; Vandamme, T. F. Nanoparticles by spray drying using innovative new technology: The BÃ1/4chi Nano Spray Dryer B-90. J. Control. Release., 2010, 147, 304-310.
20. Lu, B.; Zhang, J.Q.; Yang, H. Lung-targeting microspheres of carboplatin. Int. J. Pharm., 2003, 265, 1-11.
21. Dasankoppa, F.; Sholapur, H.; Ningangowdar, M. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac. J. Basic Clin. Pharm., 2013, 4(1): 2-9.
22. Harsha, S.; Attimarad, M.; Khan, T.; Anroop, N.; Aldhubiab, B.; Sangi, S.; Shariff, A. Design and formulation of mucoadhesive microspheres of sitagliptin. J. Microencapsul., 2013, 30, 257-264.
23. Harsha, S.; R, C.; Rani, S. Ofloxacin targeting to lungs by way of microspheres. Int. J. Pharm., 2009, 380, 127-132.
24. Yan-Ling, H.; Ron, S.; Gilles-Jacques, R.; Gangadhar, S.; Selene, L.; Monica, L.-S.; Mitchell, R.; William, P.D.; Dan, H. Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Curr. Med. Res. Opin., 2007, 23, 1131-1138.
25. Alexakis, T.; Boadi, D.; Quong, D.; Groboillot, A.; O'Neill, I.; Poncelet, D.; Neufeld, R. Microencapsulation of DNA Within alginate microspheres and crosslinked chitosan membranes for in vivo application. Appl. Biochem. Biotechnol., 1995, 50, 93-106.
26. Barua, C.; Pathak, D.; Sarma, D.; Borah, R.; Begum, S. Healing efficacy of methanol extract of leaves of Alternanthera brasiliana Kuntze in aged wound model. J. Basic Clin. Pharm., 2012, 3(4), 341-345.
27. Dhaliwal, S.; Jain, S.; Singh, H.; Tiwary, A. Mucoadhesive Microspheres for Gastroretentive Delivery of Acyclovir: In vitro and In vivo Evaluation. AAPS J. 2008, 10, 322-330.
28. Bayomi, M.A.; Al-Suwayeh, S.A.; El-Helw, A.M.; Mesnad, A.F. Preparation of casein "chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharm. Acta Helv., 1998, 73, 187-192.
29. Hasçiçek, C.; Gönül, N.; Erk, N. Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization. Il Farmaco 2003, 58, 11-16.
30. Rao, K.V.R.; Buri, P. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int. J. Pharm. 1989, 52, 265-270.
31. Edlund, U.; Svensson, M.; Albertsson, A.-C. Microsphere valorization of forestry derived hydrolysates. Eur. Polym. J., 2012, 48, 372-383.
32. Silverstein, R.M.; Bassler, G.C.; Morrill, T.C. Spectrometric identification of organic compounds. Wiley: 1991.
33. Kathiravan, G.; Sureban, S.M.; Sree, H.N.; Bhuvaneshwari, V.; Kramony, E. Isolation of anticancer drug TAXOL from Pestalotiopsis breviseta with apoptosis and B-Cell lymphoma protein docking studies. J. B. Clin. Pharma., 2008, 4, 14-19.
34. Shah, M.; Pathak, K. Development and Statistical Optimization of Solid Lipid Nanoparticles of Simvastatin by Using 23 Full-Factorial Design. AAPS Pharm. Sci. Tech., 2010, 11, 489-496.
35. Ravikumara, N.R.; Tiyaboonchai, W.; Madhusudhan, B. Fabrication and Characterization of Genistein Encapsulated Poly (D, L) Lactic acid Nanoparticles for Pharmaceutical Application. Curr. Nanosci., 2013, 9, 293-302.
36. Dasankoppa, F.; Sanjeri.; Ningangowdar, M.; Sholapur, H. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac. J. B. Clinpharma., 2013, 4, 2-9.
37. Burkey, B.F.; Li, X.; Bolognese, L.; Balkan, B.; Mone, M.; Russell, M.; Hughes, T. E.; Wang, P. R. Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats. J. Pharmacol. Exp. Ther., 2005, 315, 688-695.
38. Harsha, N.S.; Rani, R.H.S. Drug targeting to lungs by way of microspheres. Arch. Pharm. Res., 2006, 29, 598-604.
39. Atuah, K.N.; Walter, E.; Merkle, H.P.; Alpar, H.O. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. J. Microencapsul. 2003, 20, 387-399.
40. Burrki, K.; Jeon, I.; Arpagaus, C.; Betz, G. New insights into respirable protein powder preparation using a nano spray dryer. Int. J. Pharm. 2011, 408, 248-256.
41. Schafroth, N.; Arpagaus, C.; Jadhav, U.Y.; Makne, S.; Douroumis, D. Nano and microparticle engineering of water insoluble drugs using a novel spraydrying process. Colloids Surf., B, 2012, 90, 8-15.
42. Paula, H.C.B.; Sombra, F.M.; Abreu, F.v.O.M.; de Paul, R.C.M. Lippia sidoides essential oil encapsulation by angico gum/chitosan nanoparticles. J. Brazil. Chem. Soc., 2010, 21, 2359-2366.
43. Samy, W.; Elgindy, N.; El-Gowelli, H.M. Biopolymeric nifedipine powder for acceleration of wound healing. Int. J. Pharm. 2012, 422, 323-331.
44. Coowanitwong, I.; Arya, V.; Kulvanich, P.; Hochhaus, G. Slow Release Formulations of Inhaled Rifampin. AAPS J., 2008, 10, 342-348.
45. Patil, P.; Joshi, P.; Paradkar, A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharm. Sci. Tech., 2004, 5, 43-50.
46. Türker, S.; Onur, E.; Ózer, Y. Nasal route and drug delivery systems. Pharm. World Sci., 2004, 26, 137-142.
47. Singh, B.; Chakkal, S.; Ahuja, N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm. Sci. Tech. 2006, 7, E19-E28.
48. Iqbal, J.; Shahnaz, G.; Dunnhaupt, S.; Muller, C.; Hintzen, F.; Bernkop-Schnurch, A. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials, 2011, 33, 1528-1535.
49. Abu-Huwaij, R.; Obaidat, R.; Sweidan, K.; Al-Hiari, Y. Formulation and In vitro Evaluation of Xanthan Gum or Carbopol 934-Based Mucoadhesive Patches, Loaded with Nicotine. AAPS Pharm. Sci. Tech., 2011, 12, 21-27.